Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Acetylator phenotype and genotype in HIV-infected patients with and without sulfonamide hypersensitivity.

Acetylator phenotype and genotype in HIV-infected patients with and without sulfonamide hypersensitivity. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Acetylator phenotype and genotype in HIV-infected patients with and without sulfonamide hypersensitivity. Abstract Text:

    william m o'neilWilliam M O'Neil,rodger d macarthurRodger D MacArthur,marti j farroughMarti J Farrough,mark a dollMark A Doll,adrian j fretlandAdrian J Fretland,david w heinDavid W Hein,lawrence r craneLawrence R Crane,craig k svenssonCraig K Svensson,

    Adverse reactions to sulfonamides occur at a higher frequency in patients infected with the human immunodeficiency virus (HIV) than noninfected patients. Some studies have suggested that patients with the slow acetylator phenotype are predisposed to these reactions, whereas other studies suggest that the slow acetylator genotype is not a predisposing factor. To rationalize these seemingly contradictory observations, the authors determined the N-acetyltransferase 2 (NAT2) genotype and phenotype in patients with and without a history of hypersensitivity reactions to sulfonamides. HIV-infected patients with a history of a delayed-type hypersensitivity reaction to trimethoprim-sulfamethoxazole were enrolled, along with a group of AIDS patients with no history of hypersensitivity (delayed or immediate). NAT2 phenotype was determined in both groups using dapsone, while the genotype was determined using a polymerase chain reaction-restriction fragment length polymorphism assay. Ten of 14 patients (71%) with a history of hypersensitivity exhibited the slow acetylator phenotype, while 8 of 14 patients (57%) without such a history exhibited this same phenotype (odds ratio [OR] = 1.9, 95% confidence interval [CI] = 0.4-9.0; p = 0.69, Fisher's Exact Test). While 9 of 14 patients (64%) with a history of hypersensitivity exhibited a slow acetylator genotype, only 4 of 14 patients (29%) without such a history exhibited this genotype (ns). There were more instances of discordance between deduced and actual phenotype in the nonhypersensitive patients (n = 4) than in the hypersensitive patients (n = 1). The reported higher frequency of the slow acetylator phenotype among patients with a history of hypersensitivity to sulfonamides does not appear to be explained by metabolic changes that would cause discordance between acetylator genotype and phenotype.

    Acetylator phenotype and genotype in HIV-infected patients with and without sulfonamide hypersensitivity. Publishing Authors By Initials

    wm o'neilWM O'Neil,rd macarthurRD MacArthur,mj farroughMJ Farrough,ma dollMA Doll,aj fretlandAJ Fretland,dw heinDW Hein,lr craneLR Crane,ck svenssonCK Svensson,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Acetylator phenotype and genotype in HIV-infected patients with and without sulfonamide hypersensitivity. Journal Published:

    PUBLICATION TYPE: Research Support, U.S. Gov't,

    Journal: Journal of clinical pharmacology

    VOLUME: 42

    Page Numbers: 613-9

    Journal Abbreviation:

    ISSN: 0091-2700

    DAY: 17

    MONTH: Jun

    YEAR: 2002

    Acetylator phenotype and genotype in HIV-infected patients with and without sulfonamide hypersensitivity. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 366372

    Acetylator phenotype and genotype in HIV-infected patients with and without sulfonamide hypersensitivity. Keywords Mesh Terms:

    KEYWORDS: Trimethoprim-Sulfamethoxazole Combinatio

    MESH TERMS: adverse effects

    Chemical & Substance for Abstract: Acetylator phenotype and genotype in HIV-infected patients with and without sulfonamide hypersensitivity. Information

    Substance Name: NAT2 protein, human

    Registry Number: EC 2.3.1.5

    Grant and Affiliation Information for Acetylator phenotype and genotype in HIV-infected patients with and without sulfonamide hypersensitivity.

    AFFILIATION: Department of Pharmaceutical Sciences, Wayne State University, Detroit, Michigan 48202, USA.

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY: United States NCI

    GRANT: R01 CA034627-16

    ACRONYM: CA

    MEDLINETA: J Clin Pharmacol

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Acetylator phenotype and genotype in HIV-infected patients with and without sulfonamide hypersensitivity Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News